| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 33.90B | 34.63B | 36.48B | 40.70B | 45.24B | 41.33B |
| Gross Profit | 13.60B | 13.79B | 14.28B | 14.86B | 16.57B | 16.47B |
| EBITDA | 9.68B | 10.09B | 9.41B | 9.70B | 14.11B | 6.61B |
| Net Income | 6.55B | 6.61B | 5.28B | 3.63B | 4.81B | 3.23B |
Balance Sheet | ||||||
| Total Assets | 38.92B | 40.59B | 33.08B | 32.73B | 34.27B | 40.51B |
| Cash, Cash Equivalents and Short-Term Investments | 17.11B | 19.82B | 19.93B | 17.15B | 8.31B | 12.78B |
| Total Debt | 2.72B | 3.64B | 3.77B | 5.17B | 9.27B | 16.22B |
| Total Liabilities | 8.70B | 10.75B | 9.40B | 12.19B | 15.76B | 24.62B |
| Stockholders Equity | 30.21B | 29.84B | 23.68B | 20.54B | 18.50B | 15.89B |
Cash Flow | ||||||
| Free Cash Flow | 5.32B | 6.27B | 5.85B | 14.77B | 1.04B | -1.77B |
| Operating Cash Flow | 5.80B | 6.72B | 6.05B | 14.96B | 1.61B | -1.14B |
| Investing Cash Flow | -6.74B | -4.63B | 606.00M | 52.00M | 2.16B | 456.00M |
| Financing Cash Flow | -2.89B | -2.21B | -3.88B | -6.18B | -8.29B | 4.61B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
81 Outperform | ¥45.37B | 16.95 | ― | 4.59% | 0.63% | -24.87% | |
80 Outperform | $24.67B | 5.50 | 24.14% | 0.85% | 6.43% | 368.06% | |
74 Outperform | ¥40.09B | 17.18 | ― | 2.98% | -0.90% | -13.24% | |
72 Outperform | ¥36.23B | 6.85 | ― | 4.40% | -8.78% | -17.28% | |
67 Neutral | ¥29.32B | 9.10 | ― | 2.55% | 20.13% | 33.43% | |
64 Neutral | ¥4.82B | 3.69 | ― | 0.54% | 4.93% | 23.92% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% |